DisProt: intrinsic protein disorder annotation in 2020

András Hatos, Borbála Hajdu-Soltész, Alexander Miguel Monzon, Nicolas Palopoli, Lucía Álvarez, Burcu Aykaç Fas, Claudio Bassot, Guillermo I. Benítez, Martina Bevilacqua, Anastasia Chasapi, Lucía B. Chemes, Norman E. Davey, Radoslav Davidovic, A. Keith Dunker, Arne Elofsson, Julien Gobeill, Nicolás S. González Foutel, Govindarajan Sudha, Mainak Guharoy, Tamás Horváth, Valentin Iglesias, Andrey V. Kajava, Orsolya P. Kovács, John Lamb, Matteo Lambrughi, Tamas Lazar, Jeremy Y. Leclercq, Emanuela Leonardi, Sandra Macedo-Ribeiro, Mauricio Macossay-Castillo, Emiliano Maiani, José A. Manso, Cristina Marino Buslje, Elizabeth Martínez-Pérez, Bálint Mészáros, Ivan Micetic, Giovanni Minervini, Nikoletta Murvai, Marco Necci, Christos A. Ouzounis, Mátyás Pajkos, Lisanna Paladin, Rita Pancsa, Elena Papaleo, Gustavo D. Parisi, Emilie Pasche, Pedro J. Barbosa Pereira, Vasilis J. Promponas, Jordi Pujols, Federica Quaglia, Patrick Ruch, Marco Salvatore, Éva Schád, Beáta Szabó, Tamás Szaniszló, Stella Tamana, Ágnes Tantos, Nevena Veljkovic, Salvador Ventura, Wim F. Vranken, Zsuzsanna Dosztányi, Peter Tompa, Silvio C. E. Tosatto, Damiano PiovesanNucleic Acids Res 2020 · DOI

TL;DR

The DisProt database, a crucial resource for understanding intrinsically disordered proteins (IDPs), has been significantly updated to version 8. This release doubles the number of annotated proteins, introduces a new, formalized disorder ontology, and features a completely redesigned website with enhanced search capabilities and a more flexible annotation format, aiming to accelerate research into the "dark proteome."

What Problem Does This Paper Address?

A substantial portion of the eukaryotic proteome, estimated to be around half, is considered "dark" due to a lack of structural information. Intrinsically disordered proteins (IDPs) and regions (IDRs) are a major component of this dark proteome, yet they play critical roles in cellular signaling, regulation, and are increasingly implicated in diseases. Understanding these dynamic, non-globular protein regions is essential for functional characterization and for developing new therapeutic strategies. However, manually curated annotations of IDPs are scarce, and existing databases have limitations. This paper addresses the need for a more comprehensive, accessible, and interoperable resource for IDP annotation by presenting the latest version of the DisProt database.

Methods

The core of this work is the significant update and redesign of the DisProt database. Key methodological advancements include:

  • New Annotation Paradigm: The focus has shifted from experimental methods as the core of an annotation to the functional/structural aspect of a region, with experimental methods now serving as an attribute. This allows for a more nuanced representation of disorder.
  • Formalized Disorder Ontology (DO): The new ontology is formalized and interoperable, adopting OWL format. This structured vocabulary improves data exchange and allows for richer term definitions, including cross-references and synonyms.
  • Redesigned Website and Interface: The website features a new graphical interface, improved search engine, and a clearer API for programmatic access. A new annotation interface integrates text-mining technologies to streamline the curation process.
  • Enhanced Annotation Format: The new entry format offers greater flexibility, simplifies maintenance, and allows for the capture of more detailed information from the literature, including a "statement" field to directly link evidence to literature text.
  • Text Mining Integration: The annotation interface leverages text-mining technologies and tools like SciLite and EuropePMC API to assist curators in identifying relevant literature and biological entities.

Datasets

The primary dataset is the DisProt database itself, which is continuously updated.

  • DisProt Version 8: This release contains 1556 proteins and 3511 sequence segments annotated as disordered, representing a doubling of entries compared to the previous version (DisProt 7).
  • Comparison to DisProt 7: The paper uses DisProt 7 as a baseline for comparison, particularly in figures illustrating region length distribution.
  • Integration with Other Databases: DisProt aims for interoperability with other databases like MobiDB, UniProtKB, IDEAL, ELM, DIBS, and MFIB, incorporating data where appropriate.

Key Insights and Ideas

  • The "Dark Proteome" is Vast and Important: The paper reiterates that a significant fraction of proteins lack structural information, highlighting the critical need to study IDPs for a complete understanding of protein function.
  • Disorder is Not Just a Lack of Structure, but a Functional State: The updated ontology and annotation scheme reflect a growing understanding that IDPs are not simply unfolded proteins but possess distinct functional roles and structural ensembles.
  • Formalization is Key for Interoperability: Adopting OWL for the Disorder Ontology is a crucial step towards seamless data integration and sharing within the bioinformatics community.
  • Text Mining Accelerates Curation: The integration of text-mining tools significantly improves the efficiency and effectiveness of manual annotation, a bottleneck in database development.
  • DisProt as a Foundation for Prediction and Therapy: The growth and improved annotation quality of DisProt are expected to accelerate the development and validation of disorder predictors and potentially aid in the rational design of drugs targeting IDPs.

Key Results

  • Doubled Database Size: DisProt 8 contains nearly twice the number of proteins and disordered regions compared to DisProt 7.
  • Improved Annotation Coverage: 19.7% of residues are annotated as disordered in DisProt 8 (or 18.7% when ambiguous evidence is excluded).
  • Enhanced Data Representation: The new annotation format and ontology allow for more detailed and flexible capture of functional and structural aspects of disordered regions.
  • Streamlined Curation: The new annotation interface, with text-mining integration, has made the curation process faster and more effective.
  • Community-Driven Ontology: The Disorder Ontology is maintained by the DisProt consortium, fostering collaborative development and adoption.

Limitations and Future Work

  • Ambiguous Evidence Handling: While the new format allows for tracking ambiguous evidence, the paper notes that regions shorter than ten residues are now marked as obsolete, indicating a refinement in what constitutes a meaningful annotation.
  • Order Annotation: The paper acknowledges that only a small number of proteins are annotated with the "order" term and expresses a future goal to encourage curators to track information about ordered states, especially in the context of structural transitions.
  • Precision in Interaction Sites: The paper mentions that in the previous DisProt version, binding residues were overestimated due to database schema limitations. The new version aims for more precise identification of interaction sites.
  • Future Ontology Development: The Disorder Ontology is expected to evolve, particularly the "Biological condensation" branch, as the field matures.
  • Continued Curation and Community Involvement: DisProt actively seeks new curators and emphasizes its role as a community database, aiming for long-term sustainability through initiatives like ELIXIR.

Summary updated

BibTeX
@article{hatos2020disprot,
  author = {András Hatos and Borbála Hajdu-Soltész and Alexander Miguel Monzon and Nicolas Palopoli and Lucía Álvarez and Burcu Aykaç Fas and Claudio Bassot and Guillermo I. Benítez and Martina Bevilacqua and Anastasia Chasapi and Lucía B. Chemes and Norman E. Davey and Radoslav Davidovic and A. Keith Dunker and Arne Elofsson and Julien Gobeill and Nicolás S. González Foutel and Govindarajan Sudha and Mainak Guharoy and Tamás Horváth and Valentin Iglesias and Andrey V. Kajava and Orsolya P. Kovács and John Lamb and Matteo Lambrughi and Tamas Lazar and Jeremy Y. Leclercq and Emanuela Leonardi and Sandra Macedo-Ribeiro and Mauricio Macossay-Castillo and Emiliano Maiani and José A. Manso and Cristina Marino Buslje and Elizabeth Martínez-Pérez and Bálint Mészáros and Ivan Micetic and Giovanni Minervini and Nikoletta Murvai and Marco Necci and Christos A. Ouzounis and Mátyás Pajkos and Lisanna Paladin and Rita Pancsa and Elena Papaleo and Gustavo D. Parisi and Emilie Pasche and Pedro J. Barbosa Pereira and Vasilis J. Promponas and Jordi Pujols and Federica Quaglia and Patrick Ruch and Marco Salvatore and Éva Schád and Beáta Szabó and Tamás Szaniszló and Stella Tamana and Ágnes Tantos and Nevena Veljkovic and Salvador Ventura and Wim F. Vranken and Zsuzsanna Dosztányi and Peter Tompa and Silvio C. E. Tosatto and Damiano Piovesan},
  title = {{DisProt: intrinsic protein disorder annotation in 2020}},
  journal = {Nucleic Acids Res.},
  year = {2020},
  doi = {10.1093/nar/gkz975},
}
Figure